ReNeuron Group plc
RNUGF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 31.5% | 56.8% | -95.8% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -742.1% | -1,902% | -3,597.7% | -169.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,201.9% | -2,657.3% | -5,057.6% | -221% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,020.4% | -2,404.2% | -4,415.2% | -188.2% |
| EPS Diluted | -0.095 | -0.17 | -0.29 | -0.35 |
| % Growth | 44.3% | 41.4% | 17.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |